ADIPOQ and schizophrenia: In addition to disruption in reducing food intake, low adiponectin levels in persons with schizophrenia treated with antipsychotics were associated with increased insulin resistance, high blood pressure, hypertriglyceridemia, and low high-density lipoprotein cholesterol [81,82].